Baidu
map

EASD 2014:1型糖尿病:胰岛素泵优于每日多次注射胰岛素

2014-09-22 张永燊、陈智 CMT糖尿病

奥地利维也纳时间9月16日,第50届欧洲糖尿病研究学会年会(EASD 2014)在奥地利维也纳开幕。本报报道团队亲历EASD 2014,向您传递会议精彩内容,希望能给您亲临会场的感觉。如果您或者您的同事在EASD会议现场,请给中国医学论坛报糖尿病微信后台留言,留下照片,留下声音,让我们身在国内的同行也能感受到现场的气氛吧! 研究介绍 在本届EASD年会上,瑞典哥德堡大学So

奥地利维也纳时间9月16日,第50届欧洲糖尿病研究学会年会(EASD 2014)在奥地利维也纳开幕。本报报道团队亲历EASD 2014,向您传递会议精彩内容,希望能给您亲临会场的感觉。如果您或者您的同事在EASD会议现场,请给中国医学论坛报糖尿病微信后台留言,留下照片,留下声音,让我们身在国内的同行也能感受到现场的气氛吧!

研究介绍

在本届EASD年会上,瑞典哥德堡大学Soffia Gudbj rnsdottir博士和同事报告的对瑞典全国糖尿病登记的观察性研究显示,与每日多次注射胰岛素相比,用胰岛素泵可使1型糖尿病患者全因死亡降低29%,发生致死性心血管病(CVD,包括冠心病和卒中)的风险降低44%。

胰岛素泵(持续皮下胰岛素输注,CSII)已应用超过30年。然而,目前几乎没有研究评估CSII对CVD和死亡长期风险的影响。这项研究旨在评估与每日多次注射胰岛素相比,使用胰岛素泵治疗对1型糖尿病患者CVD和死亡的影响。

研究者对瑞典全国糖尿病登记研究中的18168例1型糖尿病患者进行分析,其中接受CSII的患者(胰岛素泵组)为2441例,每日多次注射胰岛素的患者(注射组)为15727例,平均随访6.8年。

结果显示,胰岛素泵组患者死于任何原因的概率比注射组患者低29%,发生致死性CVD的可能性低43%,上述结果均具有统计学意义。此外,与注射组患者相比,胰岛素泵组患者发生致死性或非致死性冠心病的风险降低18%,但差异未达显著性(P=0.06);未观察到胰岛素泵组患者的致死性/非致死性CVD及非CVD死亡风险显著降低。

专家访谈

现场报告结束后,Gudbj rnsdottir博士接受了本报记者采访。

《中国医学论坛报》(简称“《论坛报》”):在胰岛素泵组与注射组的比较中,为什么只在致死性CVD和总死亡方面存在显著差异?

Gudbj rnsdottir博士一开始我们认为一些未检测的混杂因素,如护理类型、血糖达标频率、糖尿病教育、使用持续血糖监测(CGM)、依从性,可能会影响结果。因此,我们进行了敏感性分析,但是结果显示这些混杂因素不太可能影响结果。从研究结果我们只能观察到致死性CVD存在差异是总死亡存在差异的主要原因,但是我们不能确定致死性CVD和总死亡在两组存在显著差异、而其他因素无显著差异的原因。

《论坛报》:基于这项研究的结果,可以认为在1型糖尿病患者中,胰岛素泵治疗具有一定的心血管保护作用吗?

Gudbj rnsdottir博士:这项研究显示1型糖尿病患者用胰岛素泵治疗可以减少心血管长期并发症。然而,值得注意的是,本研究中接受胰岛素泵治疗的患者是从瑞典全国糖尿病登记(覆盖全瑞典所有已知1型糖尿病患者的95%)中的1型糖尿病患者中选出来的,这是因为他们能够、也愿意学习使用胰岛素泵。我们仍须继续随访这些患者,观察胰岛素泵治疗的益处能持续多久。此外,我们不清楚本研究入组患者符合哪些使用胰岛素的适应证,因此不能确定胰岛素泵治疗的这种益处是否只出现于具有特定适应证的患者,将来我们需要获得更多这方面的信息。


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=26069, encodeId=683c2606956, content=好好学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Fri Jun 05 16:25:00 CST 2015, time=2015-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20578, encodeId=b1db205e870, content=控制好糖尿病可能提高肝硬化患者的预后。, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:13:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690587, encodeId=21ca169058e7f, content=<a href='/topic/show?id=5c472843a1' target=_blank style='color:#2F92EE;'>#ASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2843, encryptionId=5c472843a1, topicName=ASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8529069357, createdName=okhuali, createdTime=Fri Jul 03 15:13:00 CST 2015, time=2015-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749499, encodeId=cba01e4949972, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Mon Apr 13 11:13:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534081, encodeId=fceb153408172, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6436, encryptionId=576e643634, topicName=EASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21f812527653, createdName=qilu_qi, createdTime=Wed Sep 24 00:13:00 CST 2014, time=2014-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545292, encodeId=ad761545292a3, content=<a href='/topic/show?id=d49b8390451' target=_blank style='color:#2F92EE;'>#胰岛素泵#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83904, encryptionId=d49b8390451, topicName=胰岛素泵)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=739113711075, createdName=12498a1cm71暂无昵称, createdTime=Wed Sep 24 00:13:00 CST 2014, time=2014-09-24, status=1, ipAttribution=)]
    2015-06-05 ljjj1053

    好好学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=26069, encodeId=683c2606956, content=好好学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Fri Jun 05 16:25:00 CST 2015, time=2015-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20578, encodeId=b1db205e870, content=控制好糖尿病可能提高肝硬化患者的预后。, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:13:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690587, encodeId=21ca169058e7f, content=<a href='/topic/show?id=5c472843a1' target=_blank style='color:#2F92EE;'>#ASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2843, encryptionId=5c472843a1, topicName=ASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8529069357, createdName=okhuali, createdTime=Fri Jul 03 15:13:00 CST 2015, time=2015-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749499, encodeId=cba01e4949972, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Mon Apr 13 11:13:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534081, encodeId=fceb153408172, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6436, encryptionId=576e643634, topicName=EASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21f812527653, createdName=qilu_qi, createdTime=Wed Sep 24 00:13:00 CST 2014, time=2014-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545292, encodeId=ad761545292a3, content=<a href='/topic/show?id=d49b8390451' target=_blank style='color:#2F92EE;'>#胰岛素泵#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83904, encryptionId=d49b8390451, topicName=胰岛素泵)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=739113711075, createdName=12498a1cm71暂无昵称, createdTime=Wed Sep 24 00:13:00 CST 2014, time=2014-09-24, status=1, ipAttribution=)]
    2015-04-11 x35042875

    控制好糖尿病可能提高肝硬化患者的预后。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=26069, encodeId=683c2606956, content=好好学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Fri Jun 05 16:25:00 CST 2015, time=2015-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20578, encodeId=b1db205e870, content=控制好糖尿病可能提高肝硬化患者的预后。, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:13:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690587, encodeId=21ca169058e7f, content=<a href='/topic/show?id=5c472843a1' target=_blank style='color:#2F92EE;'>#ASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2843, encryptionId=5c472843a1, topicName=ASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8529069357, createdName=okhuali, createdTime=Fri Jul 03 15:13:00 CST 2015, time=2015-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749499, encodeId=cba01e4949972, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Mon Apr 13 11:13:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534081, encodeId=fceb153408172, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6436, encryptionId=576e643634, topicName=EASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21f812527653, createdName=qilu_qi, createdTime=Wed Sep 24 00:13:00 CST 2014, time=2014-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545292, encodeId=ad761545292a3, content=<a href='/topic/show?id=d49b8390451' target=_blank style='color:#2F92EE;'>#胰岛素泵#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83904, encryptionId=d49b8390451, topicName=胰岛素泵)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=739113711075, createdName=12498a1cm71暂无昵称, createdTime=Wed Sep 24 00:13:00 CST 2014, time=2014-09-24, status=1, ipAttribution=)]
    2015-07-03 okhuali
  4. [GetPortalCommentsPageByObjectIdResponse(id=26069, encodeId=683c2606956, content=好好学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Fri Jun 05 16:25:00 CST 2015, time=2015-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20578, encodeId=b1db205e870, content=控制好糖尿病可能提高肝硬化患者的预后。, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:13:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690587, encodeId=21ca169058e7f, content=<a href='/topic/show?id=5c472843a1' target=_blank style='color:#2F92EE;'>#ASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2843, encryptionId=5c472843a1, topicName=ASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8529069357, createdName=okhuali, createdTime=Fri Jul 03 15:13:00 CST 2015, time=2015-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749499, encodeId=cba01e4949972, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Mon Apr 13 11:13:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534081, encodeId=fceb153408172, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6436, encryptionId=576e643634, topicName=EASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21f812527653, createdName=qilu_qi, createdTime=Wed Sep 24 00:13:00 CST 2014, time=2014-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545292, encodeId=ad761545292a3, content=<a href='/topic/show?id=d49b8390451' target=_blank style='color:#2F92EE;'>#胰岛素泵#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83904, encryptionId=d49b8390451, topicName=胰岛素泵)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=739113711075, createdName=12498a1cm71暂无昵称, createdTime=Wed Sep 24 00:13:00 CST 2014, time=2014-09-24, status=1, ipAttribution=)]
    2015-04-13 baoya
  5. [GetPortalCommentsPageByObjectIdResponse(id=26069, encodeId=683c2606956, content=好好学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Fri Jun 05 16:25:00 CST 2015, time=2015-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20578, encodeId=b1db205e870, content=控制好糖尿病可能提高肝硬化患者的预后。, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:13:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690587, encodeId=21ca169058e7f, content=<a href='/topic/show?id=5c472843a1' target=_blank style='color:#2F92EE;'>#ASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2843, encryptionId=5c472843a1, topicName=ASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8529069357, createdName=okhuali, createdTime=Fri Jul 03 15:13:00 CST 2015, time=2015-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749499, encodeId=cba01e4949972, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Mon Apr 13 11:13:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534081, encodeId=fceb153408172, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6436, encryptionId=576e643634, topicName=EASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21f812527653, createdName=qilu_qi, createdTime=Wed Sep 24 00:13:00 CST 2014, time=2014-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545292, encodeId=ad761545292a3, content=<a href='/topic/show?id=d49b8390451' target=_blank style='color:#2F92EE;'>#胰岛素泵#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83904, encryptionId=d49b8390451, topicName=胰岛素泵)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=739113711075, createdName=12498a1cm71暂无昵称, createdTime=Wed Sep 24 00:13:00 CST 2014, time=2014-09-24, status=1, ipAttribution=)]
    2014-09-24 qilu_qi
  6. [GetPortalCommentsPageByObjectIdResponse(id=26069, encodeId=683c2606956, content=好好学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ac181616815, createdName=ljjj1053, createdTime=Fri Jun 05 16:25:00 CST 2015, time=2015-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=20578, encodeId=b1db205e870, content=控制好糖尿病可能提高肝硬化患者的预后。, beContent=null, objectType=article, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150920/IMG55FDE671A89482379.jpg, createdBy=cef3108336, createdName=x35042875, createdTime=Sat Apr 11 23:13:00 CST 2015, time=2015-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1690587, encodeId=21ca169058e7f, content=<a href='/topic/show?id=5c472843a1' target=_blank style='color:#2F92EE;'>#ASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2843, encryptionId=5c472843a1, topicName=ASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e8529069357, createdName=okhuali, createdTime=Fri Jul 03 15:13:00 CST 2015, time=2015-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749499, encodeId=cba01e4949972, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Mon Apr 13 11:13:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534081, encodeId=fceb153408172, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6436, encryptionId=576e643634, topicName=EASD)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21f812527653, createdName=qilu_qi, createdTime=Wed Sep 24 00:13:00 CST 2014, time=2014-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545292, encodeId=ad761545292a3, content=<a href='/topic/show?id=d49b8390451' target=_blank style='color:#2F92EE;'>#胰岛素泵#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83904, encryptionId=d49b8390451, topicName=胰岛素泵)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=739113711075, createdName=12498a1cm71暂无昵称, createdTime=Wed Sep 24 00:13:00 CST 2014, time=2014-09-24, status=1, ipAttribution=)]

相关资讯

EASD 2014:心衰伴2型糖尿病患者死亡风险增加70%

瑞典卡洛林斯卡研究所的Anna Norhammar博士和Isabelle Johansson博士在欧洲糖尿病学会年会上发表了一项研究,其结果显示,在缺血性心衰患者当中,2型糖尿病在2年内增加死亡风险70%。即使是之前接受了血运重建术的患者死亡风险也增加了60%。在射血分数≥50%的患者中则稍低一些,2型糖尿病使他们的死亡风险增加了40%。研究结果来自瑞典心衰注册体系,包含自2003年以来约41,0

EASD 2014:第50届欧洲糖尿病研究学会年会预告

欧洲糖尿病年会(EASD)于1956年在意大利蒙特卡蒂尼由Dr. Joseph Hoet作为主席而创办。目前EASD的正式会员已经超过了5,500人,这些会员来自全世界100多个国家。对糖尿病研究做出过杰出贡献的医生或科学家会被授予荣誉会员,学会的第一位荣誉会员是Charles Best。50届欧洲糖尿病研究协会((European Association for the Study of

EASD 2014:主席谈EASD使命与未来

奥地利维也纳时间9月16日,第50届欧洲糖尿病研究学会年会(EASD 2014)盛大开幕。本报报道团队亲历EASD 2014,向您传递会议精彩内容,希望能给您亲临会场的感觉。如果您或者您的同事在EASD会议现场,请给中国医学论坛报糖尿病微信后台留言,留下照片,留下声音,让我们身在国内的同行也能感受到现场的气氛吧! EASD 2014概况 开幕式上,大会主席Boulton教授

EASD 2014:达格列净可安全应用于高血压糖尿病患者

 欧洲糖尿病研究学会(EASD)2014年会的一项报告表明,在高血压控制不佳的2型糖尿病患者中,达格列净(dapagliflozin)与血管紧张素转换酶抑制剂(ACEI)或血管紧张素受体拮抗剂(ARB)联用具有良好的安全性。 两项为期12周的随机、双盲研究以血糖(HbA1c 7.0-10.5%))和血压(BP: 140-164 / 85-104 mmHg)控制不佳的2型糖尿病患

EASD 2014大会日程概览

        于奥地利维也纳召开的欧洲糖尿病研究学会(EASD)2014年会将迎来50华诞,预计将有近20000位与会者参加此次大会,预计规模超过国际糖尿病联盟(IDF)和美国糖尿病学会(ADA)会议。         以下为会

EASD 2014:各国“抗糖”成果展示

EASD 2014正式会议的第1天,除了开幕式及Claude Bernard奖颁奖以外,给小编留下最深印象的无疑是EASD在长长的会场走廊两侧给各国和糖尿病相关组织提供展位,供他们展示各国抗击糖尿病的成果。遗憾的是,几乎没有非洲国家进行展示。 首先来看看代表中国在EASD 2014展示的中华医学会糖尿病学分会(CDS)。CDS展示了我国在“世界糖尿病日”和历届CDS年会的宣传成果。小编拍

Baidu
map
Baidu
map
Baidu
map